DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Bernhard J, Luo W, Ribi K et al.
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
Lancet Oncol 2015;
16: 848-858
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.